Brief: Liminal Biosciences Inc - Plans To Divest Its Remaining Non-Core Assets, To Further Extend Runway
Jan 6 (Reuters) - Liminal BioSciences Inc LMNL.O :
* LIMINAL BIOSCIENCES INC - PLANS TO DIVEST ITS REMAINING
NON-CORE
ASSETS, TO FURTHER EXTEND RUNWAY
* LIMINAL BIOSCIENCES INC - OXER1 ANTAGONIST DEVELOPMENT
PROGRAM
PROGRESSING TO IDENTIFICATION OF LEAD PRECLINICAL DRUG CANDIDATE
IN H1 2023
* LIMINAL BIOSCIENCES INC - CLOSED DECEMBER 2022 WITH JUST
OVER
CAD 37 MILLION CASH ON HAND, EXPECTING TO PROVIDE A RUNWAY INTO
EARLY 2024
Source text for Eikon: ID:nCNWHHFX3a
Further company coverage: LMNL.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Liminal BioSciences
See all newsBrief: Liminal Biosciences Announces Completion Of The Plan Of Arrangement With Structured Alpha Lp
Brief: Liminal Biosciences Files Amended Schedule 13E-3 And Supplement To Management Information Circular
Brief: Liminal Biosciences Obtains Interim Order For Proposed Arrangement With Structured Alpha Lp
U.S. STOCKS ON THE MOVE-Liminal Biosciences, Tesla, Quad/Graphics
U.S. STOCKS ON THE MOVE-T2 Biosystems, GoodRx Holdings, ShiftPixy